Avaliação de gamopatias monoclonais

Last reviewed: 20 Aug 2025
Last updated: 31 Mar 2022

Summary

Diferenciales

Común

  • Gamopatia monoclonal de significado indeterminado
  • Leucemia linfocítica crônica
  • Linfoma não Hodgkin
Todos los datos

Infrecuente

  • Doença de depósito de cadeia leve
  • Gamopatias monoclonais pós-transplante
  • Mieloma múltiplo
  • Leucemia de plasmócitos
  • Macroglobulinemia de Waldenström
  • Plasmacitoma solitário
  • Síndrome POEMS (polineuropatia, organomegalia, endocrinopatia, proteína M e alterações cutâneas)
  • Hepatite C
  • Infecção pelo vírus da imunodeficiência humana (HIV)
  • Amiloidose primária
  • Crioglobulinemia
  • Lúpus eritematoso sistêmico (LES)
  • Artrite reumatoide
  • Artrite psoriática
  • Síndrome de Sjögren
  • Síndrome de Schnitzler
Todos los datos

Colaboradores

Autores

Shaji Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies

Division of Hematology

Mayo Clinic

Rochester

MN

Divulgaciones

SK has received research funding for clinical trials for his institution from: Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Astra-Zeneca, Novartis, Roche-Genentech, Takeda, and Tenebio. SK has participated in consulting and advisory boards (with no personal payment) for Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, KITE, Astra-Zeneca, Bluebird Bio, and (with personal payment) Oncopeptides, Beigene, and Antengene.

Revisores por pares

Antonio Palumbo, MD

Associate Professor

University of Turin

Chief

Myeloma Unit

Ospedale Molinette

Turin

Italy

Divulgaciones

AP declares that he has no competing interests.

John R. Wingard, MD

Price Eminent Scholar and Professor of Medicine Director

Bone Marrow Transplant Program

Division of Hematology and Oncology

University of Florida College of Medicine

Gainesville

FL

Divulgaciones

JRW declares that he has no competing interests.

John Densmore, MD, PhD

Associate Professor of Clinical Medicine

Department of Medicine

Division of Hematology/Oncology

University of Virginia

Charlottesville

VA

Divulgaciones

JD declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc. 2006 May;81(5):693-703. Resumen

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003 Jun;121(5):749-57. Resumen

Katzmann JA, Dispenzieri A. Screening algorithms for monoclonal gammopathies. Clin Chem. 2008 Nov;54(11):1753-5.Texto completo  Resumen

Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002 Feb 21;346(8):564-9.Texto completo  Resumen

Kyle RA, Durie BG, Rajkumar SV, et al; International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010 Jun;24(6):1121-7. Resumen

Dispenzieri A, Kyle R, Merlini G, et al; International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009 Feb;23(2):215-24. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Avaliação de gamopatias monoclonais images
  • Guías de práctica clínica

    • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
    • Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
    Más Guías de práctica clínica
  • Folletos para el paciente

    Linfoma não Hodgkin

    Hepatite C: o que é?

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad